Immunology of the antiphospholipid antibody syndrome
- 1 September 1996
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 39 (9) , 1444-1454
- https://doi.org/10.1002/art.1780390903
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Comparison of an enzyme‐linked immunosorbent assay for antibodies to β2‐glycoprotein I and a conventional anticardiolipin immunoassayArthritis & Rheumatism, 1996
- Inhibition of prothrombin activation by antiphospholipid antibodies and β2‐glycoprotein 1British Journal of Haematology, 1994
- Autoantibodies to Vascular Heparan Sulfate Proteoglycan in Systemic Lupus Erythematosus React with Endothelial Cells and Inhibit the Formation of Thrombin-Antithrombin III ComplexesClinical Immunology and Immunopathology, 1994
- β2‐glycoprotein 1 (β2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodiesBritish Journal of Haematology, 1992
- Lupus‐like anticoagulant properties of murine monoclonal antibodies to β2‐glycoprotein IBritish Journal of Haematology, 1992
- Molecular definition of human β2-glycoprotein (α2-GPI) by cDNA cloning and inter-species differences of β2-GPI in alternation of anticardiolipin bindingInternational Immunology, 1991
- Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene columnBiochemical and Biophysical Research Communications, 1988
- β2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregationAtherosclerosis, 1987
- Complement system proteins which interact with C3b or C4b A superfamily of structurally related proteinsImmunology Today, 1986
- The natural history of systemic lupus erythematosus: An approach to its study through chronic biologic false positive reactorsJournal of Chronic Diseases, 1955